Elevance Health’s $2.5 billion acquisition of Blue Cross and Blue Shield of Louisiana is facing some hiccups, according to an Aug. 22 article from the New Orleans Times-Picayune. The Louisiana Blues affiliate must reissue ballots to 92,000 policyholders that will allow them to approve or reject the sale and invalidate proxy ballots that it’s already received. The insurer will also reschedule a meeting and official vote until after the state’s Dept. of Insurance has held a two-day hearing on the proposed sale. State officials have been critical of the deal, and the Times-Picayune also reported that attorneys in the state Dept. of Insurance “fully expect litigation” over the deal. Elevance stands to grow its total medical enrollment by more than 1 million lives with the acquisition, expanding its Louisiana market from 301,704 members to 1.37 million members.
Source: AIS’s Directory of Health Plans